Vitro Biopharma, Inc. Quarterly Deferred Tax Assets, Valuation Allowance in USD from Q3 2014 to Q3 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Vitro Biopharma, Inc. quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from Q3 2014 to Q3 2023.
  • Vitro Biopharma, Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending October 31, 2023 was $5.05M, a 36.2% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2023 $5.05M +$1.34M +36.2% Oct 31, 2023 10-K 2024-01-29
Q3 2022 $3.71M Oct 31, 2022 10-K 2024-01-29
Q3 2015 -$1.26M -$82.2K -7% Oct 31, 2015 10-K 2016-09-22
Q3 2014 -$1.17M Oct 31, 2014 10-K 2016-09-22
* An asterisk sign (*) next to the value indicates that the value is likely invalid.